Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
United States New Age Beverages Markets through 2028: Focus on Coconut Water, High-end CSDs, Energy drinks, Kombucha, Plant Water, Probiotics, Protein Drinks, RTD Tea and Coffee, Single Serve Drinks
Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "New Age Beverages in the U.S. through 2028" report from Beverage Marketing has been added to ResearchAndMarkets.com's offering.» Mehr auf globenewswire.com
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NewAge, Inc. (NBEV; NBEVQ) Investors of Class Action and to Actively Participate
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against NewAge, Inc. (“NewAge” or the “Company”) (NASDAQ: NBEV) (OTC: NBEVQ) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired NewAge common stock during the period from January 18, 2018 and October 18, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/nbev. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose, among other things, that: (1) NewAge never entered into a “distribution agreement” or “initiative in partnership” with the military and never had plans to sell its products at all commissaries and exchanges around the world; (2) NewAge did not have adequate inventory of its products to fulfill this reported agreement; (3) NewAge did not actually expand its product lines or distribution agreements as represented; (4) the Company lacked adequate internal controls; (5) as a result the Company had a heightened risk of regularly scrutiny and ultimately subject to an SEC investigation and action; and (6) as a result of the foregoing, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: : www.bgandg.com/nbev or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in NewAge you have until February 6, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.» Mehr auf businesswire.com
Bronstein, Gewirtz & Grossman, LLC Notifies NewAge, Inc. (NBEV; NBEVQ) Investors of Class Action and to Actively Participate
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against NewAge, Inc. (“NewAge” or the “Company”) (NASDAQ: NBEV) (OTC: NBEVQ) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired NewAge common stock during the period from January 18, 2018 and October 18, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/nbev. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose, among other things, that: (1) NewAge never entered into a “distribution agreement” or “initiative in partnership” with the military and never had plans to sell its products at all commissaries and exchanges around the world; (2) NewAge did not have adequate inventory of its products to fulfill this reported agreement; (3) NewAge did not actually expand its product lines or distribution agreements as represented; (4) the Company lacked adequate internal controls; (5) as a result the Company had a heightened risk of regularly scrutiny and ultimately subject to an SEC investigation and action; and (6) as a result of the foregoing, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: : www.bgandg.com/nbev or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in NewAge you have until February 6, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.» Mehr auf businesswire.com
Unternehmenszahlen
(EUR) | 2020 | |
---|---|---|
Umsatz | 229,47 Mio | 1,48% |
Bruttoeinkommen | 145,74 Mio | 7,08% |
Nettoeinkommen | −32,31 Mio | 59,65% |
EBITDA | −24,57 Mio | 57,26% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 0,00€ |
52 Wochen-Hoch/Tief | 0,11€ - 0,0878€ |
Dividenden | Nein |
Beta | 1,54 |
KGV (PE Ratio) | −0,23 |
KGWV (PEG Ratio) | 0,00 |
KBV (PB Ratio) | 0,06 |
KUV (PS Ratio) | 0,00 |
Unternehmensprofil
NewAge, Inc. entwickelt, vermarktet, verkauft und vertreibt gesunde Produkte in den Vereinigten Staaten, Japan, China und international. Das Unternehmen ist in zwei Segmenten tätig: Direct / Social Selling und Direct Store. Es bietet Gesundheits- und Wellnessprodukte, Energydrinks, ätherische Öle und Anti-Aging-Hautpflege, Kosmetika, Getränke, Snacks, Wasser- und Luftfilter und Körperpflegeprodukte sowie Produkte zur Gewichtsregulierung, Nahrungsergänzungsmittel, Nahrungsergänzungsmittel und Schlankheitsprodukte, Diagnoseprodukte wie DNA-Tests und Diagnosekits und -produkte sowie CBD-Produkte. Das Unternehmen bietet seine Produkte unter den Marken Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii und MaVie an. Es verkauft seine Produkte direkt an die Kunden sowie über Händler, E-Commerce-Websites und Systeme für die Direktbelieferung von Geschäften. Das Unternehmen war früher als New Age Beverages Corporation bekannt und änderte im Juli 2020 seinen Namen in NewAge, Inc. NewAge, Inc. wurde im Jahr 2010 gegründet und hat seinen Hauptsitz in Denver, Colorado.
Name | New Age Beverages |
CEO | Brent David Willis |
Sitz | Denver, colorado USA |
Website | |
Industrie | Getränke |
Börsengang | |
Mitarbeiter | 1.091 |
Ticker Symbole
Börse | Symbol |
---|---|
NASDAQ | NBEV |
Assets entdecken
Shareholder von New Age Beverages investieren auch in folgende Assets